SII stops Covishield production: Adar Poonawalla says no takers for booster shots

According to SII CEO Adar Poonawalla, booster vaccines are not in demand because of general lethargy among people and they are fed up with the pandemic.

PTIUpdated: Thursday, October 20, 2022, 07:42 PM IST
article-image
According to Adar Poonawala CEO SII, booster vaccines are not in demand because of general lethargy among people and people are fed up with the pandemic. | Twitter/ @adarpoonawalla

Chief Executive Officer of Serum Institute of India (SII), Adar Poonawalla, on Thursday said the vaccine manufacturer stopped the production of Covishield vaccine starting December 2021, and of the total stock available at that time, around 100 million doses had already expired.

Speaking to reporters on the sidelines of the annual general meeting of Developing Countries Vaccine Manufacturers Network (DCVMN), he said booster vaccines have no demand as there is general lethargy among people and also because they are fed up with the pandemic.

"Since December 2021, we stopped the production (of Covishield). We had a stock of a few hundred million doses at that time and of that, 100 million doses have already expired," said Poonawalla when asked about the update on the Covishield vaccine.

He said the SII's vaccines are allowed to be mixed.

"Now, Covovax should be allowed in two weeks. So I think they will and probably should have the policy to mix boosters. If WHO allowed it, then maybe the Indian regulator will and should allow it. But again, boosters have no demand at the moment. There is lethargy generally. People are fed up of COVID, vaccines. To be honest, I am also fed up with it. We all are," he said.

Going forward, when people take a few shots every year, they may take anti-coronavirus vaccines and other shots together, Poonawalla said, adding, "It will become that kind of a product."

"In India, there is no culture of taking flu shots as we see it in the West. We tried when we launched a few vaccines in 2010. During the H1NI pandemic in 2011, no one took it. Flu is not something that sounds scary to people. They just do not want to take it," he said.

Covishield was produced at the SII's Pune facility with a master seed from Oxford University and AstraZeneca. The SII had announced its partnership with Oxford University to manufacture the vaccine in April 2020.

(To receive our E-paper on whatsapp daily, please click here. To receive it on Telegram, please click here. We permit sharing of the paper's PDF on WhatsApp and other social media platforms.)

RECENT STORIES

Mumbai updates: City's AQI to hover around 300 for the next 2-3 days

Mumbai updates: City's AQI to hover around 300 for the next 2-3 days

Mumbai: 3,668 cyber crime cases in city till September 2022; more than 1,000 account for online,...

Mumbai: 3,668 cyber crime cases in city till September 2022; more than 1,000 account for online,...

Shivaji row: NCP, Congress give suspension of business notice in Rajya Sabha over Maharashtra Guv's...

Shivaji row: NCP, Congress give suspension of business notice in Rajya Sabha over Maharashtra Guv's...

Mumbai airport's advisory to passengers: 'Arrive at least 3.5 hrs early'

Mumbai airport's advisory to passengers: 'Arrive at least 3.5 hrs early'

Ex-Mumbai police chief Sanjay Pandey gets bail from Delhi HC in money laundering case

Ex-Mumbai police chief Sanjay Pandey gets bail from Delhi HC in money laundering case